rabacfosadine (Tanovea)

Indications

• investigational agent for treatment of
  • multiple myeloma
  • non-Hodgkin's lymphoma
  • chronic lymphocytic leukemia

Dosage

16.4 mg (injection)

More general terms

• purine
• antineoplastic agent (chemotherapeutic agent)

Database

• PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=16047979